发明名称 MiR-33 inhibitors and uses thereof to decrease inflammation
摘要 The inhibition of miRNA miR-33 is shown to promote the polarization of macrophages from an M1 to an M2 phenotype. MiR-33 inhibitors are therefore useful for treating inflammation in subjects. Endogenous microRNAs can be silenced using antagomirs. The miR-33 inhibitor is preferably an antagomir having a single-stranded nucleic acid sequence that is complementary to at least 12 contiguous nucleotides in miR-33 and therefore forms a duplex with miR-33 under physiological conditions.
申请公布号 US9241950(B2) 申请公布日期 2016.01.26
申请号 US201214114471 申请日期 2012.04.30
申请人 New York University 发明人 Moore Kathryn J.;Rayner Katey J.;Sheedy Frederick;Fernandez-Hernando Carlos;Suarez Yajaira
分类号 A61K48/00;C07H21/02;C07H21/04;A61K31/713;A61K31/712;C12N15/113 主分类号 A61K48/00
代理机构 Pabst Patent Group LLP 代理人 Pabst Patent Group LLP
主权项 1. A method for reducing inflammation comprising administering to a subject with an inflamed tissue comprising M1 macrophages, an inhibitor that specifically targets miR-33 in an amount effective to reduce inflammation in the tissue of the subject.
地址 New York NY US